rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0009924,
umls-concept:C0013072,
umls-concept:C0018787,
umls-concept:C0022038,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0035173,
umls-concept:C0042395,
umls-concept:C0063757,
umls-concept:C0205164,
umls-concept:C0377786,
umls-concept:C0441471,
umls-concept:C0971125,
umls-concept:C2936173
|
pubmed:issue |
2
|
pubmed:dateCreated |
2000-2-1
|
pubmed:abstractText |
The potential merits and disadvantages of the use of ionic or nonionic contrast media in patients undergoing percutaneous transluminal coronary angioplasty (PTCA) have been the subjects of controversy. The present study was designed to evaluate the possible influence of both types of contrast media on major adverse cardiac events (MACE) in patients undergoing PTCA.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1524-4539
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
18
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
131-6
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10637198-Aged,
pubmed-meshheading:10637198-Angioplasty, Balloon, Coronary,
pubmed-meshheading:10637198-Contrast Media,
pubmed-meshheading:10637198-Coronary Artery Bypass,
pubmed-meshheading:10637198-Double-Blind Method,
pubmed-meshheading:10637198-Female,
pubmed-meshheading:10637198-Heart Diseases,
pubmed-meshheading:10637198-Humans,
pubmed-meshheading:10637198-Intraoperative Care,
pubmed-meshheading:10637198-Ioxaglic Acid,
pubmed-meshheading:10637198-Male,
pubmed-meshheading:10637198-Middle Aged,
pubmed-meshheading:10637198-Myocardial Infarction,
pubmed-meshheading:10637198-Osmolar Concentration,
pubmed-meshheading:10637198-Recurrence,
pubmed-meshheading:10637198-Stroke,
pubmed-meshheading:10637198-Triiodobenzoic Acids
|
pubmed:year |
2000
|
pubmed:articleTitle |
Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
|
pubmed:affiliation |
Division of Cardiology, Lille University Heart Institute, Lille, France. mbertrand@univ-lille2.fr
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|